The ÄrzteZeitung reports on successes with CRP apheresis in severe COVID-19 pneumonia
18.01.2022
The article states that selective CRP apheresis could be an effective therapy option for COVID-19 patients with respiratory failure and greatly increased CRP levels, and that initial data from the German registry CACOV are encouraging.